| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |